196 related articles for article (PubMed ID: 33323540)
21. The effect of HMGB1 on the clinicopathological and prognostic features of non-small cell lung cancer.
Feng A; Tu Z; Yin B
Oncotarget; 2016 Apr; 7(15):20507-19. PubMed ID: 26840258
[TBL] [Abstract][Full Text] [Related]
22. High expression of long non-coding RNA MALAT1 in breast cancer is associated with poor relapse-free survival.
Wang Z; Katsaros D; Biglia N; Shen Y; Fu Y; Loo LWM; Jia W; Obata Y; Yu H
Breast Cancer Res Treat; 2018 Sep; 171(2):261-271. PubMed ID: 29845475
[TBL] [Abstract][Full Text] [Related]
23. The Multifaceted Role of FUT8 in Tumorigenesis: From Pathways to Potential Clinical Applications.
Shi M; Nan XR; Liu BQ
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38256141
[TBL] [Abstract][Full Text] [Related]
24. High lncSNHG15 expression may predict poor cancer prognosis: a meta-analysis based on the PRISMA and the bio-informatics analysis.
Fang SX; Chen C; Guo Q; Ke XX; Lu HL; Xu G
Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32633324
[TBL] [Abstract][Full Text] [Related]
25. Prognostic and clinicopathological significance of SNHG6 in human cancers: a meta-analysis.
Zhao S; Zhu H; Jiao R; Wu X; Ji G; Zhang X
BMC Cancer; 2020 Jan; 20(1):77. PubMed ID: 32000704
[TBL] [Abstract][Full Text] [Related]
26. Prognostic Value of L-Type Amino Acid Transporter 1 (LAT1) in Various Cancers: A Meta-Analysis.
Zhang C; Xu J; Xue S; Ye J
Mol Diagn Ther; 2020 Oct; 24(5):523-536. PubMed ID: 32410110
[TBL] [Abstract][Full Text] [Related]
27. Clinicopathological significance and prognosis of long noncoding RNA SNHG16 expression in human cancers: a meta-analysis.
Jiao R; Jiang W; Wei X; Zhang M; Zhao S; Huang G
BMC Cancer; 2020 Jul; 20(1):662. PubMed ID: 32677912
[TBL] [Abstract][Full Text] [Related]
28. Loss of α1,6-fucosyltransferase inhibits chemical-induced hepatocellular carcinoma and tumorigenesis by down-regulating several cell signaling pathways.
Wang Y; Fukuda T; Isaji T; Lu J; Im S; Hang Q; Gu W; Hou S; Ohtsubo K; Gu J
FASEB J; 2015 Aug; 29(8):3217-27. PubMed ID: 25873065
[TBL] [Abstract][Full Text] [Related]
29. The Prognostic Value and Regulatory Mechanisms of microRNA-145 in Various Tumors: A Systematic Review and Meta-analysis of 50 Studies.
Xu L; Zhang Y; Tang J; Wang P; Li L; Yan X; Zheng X; Ren S; Zhang M; Xu M
Cancer Epidemiol Biomarkers Prev; 2019 May; 28(5):867-881. PubMed ID: 30602498
[TBL] [Abstract][Full Text] [Related]
30. Prognostic and clinicopathological significance of CXCL1 in cancers: a systematic review and meta-analysis.
Zhang Z; Chen Y; Jiang Y; Luo Y; Zhang H; Zhan Y
Cancer Biol Ther; 2019; 20(11):1380-1388. PubMed ID: 31387444
[No Abstract] [Full Text] [Related]
31. Prognostic Value of PTENP1 Expression in Patients with Cancer: a Systematic Review and Meta-Analysis.
Dai C; Sheng X; Wang J; Dai Y; Kuang Y; Xu Z; Guo Y
Clin Lab; 2022 Jan; 68(1):. PubMed ID: 35023688
[TBL] [Abstract][Full Text] [Related]
32. Integrative data mining and meta-analysis to investigate the prognostic role of microRNA-200 family in various human malignant neoplasms: A consideration on heterogeneity.
Yuan L; Bing Z; Yan P; Li R; Wang C; Sun X; Yang J; Shi X; Zhang Y; Yang K
Gene; 2019 Oct; 716():144025. PubMed ID: 31394177
[TBL] [Abstract][Full Text] [Related]
33. Comprehensive N-glycan profiles of hepatocellular carcinoma reveal association of fucosylation with tumor progression and regulation of FUT8 by microRNAs.
Cheng L; Gao S; Song X; Dong W; Zhou H; Zhao L; Jia L
Oncotarget; 2016 Sep; 7(38):61199-61214. PubMed ID: 27533464
[TBL] [Abstract][Full Text] [Related]
34. Tat-Interacting Protein 30 (TIP30) Expression Serves as a New Biomarker for Tumor Prognosis: A Systematic Review and Meta-Analysis.
Xu T; Jin Z; Yuan Y; Zheng H; Li C; Hou W; Guo Q; Hua B
PLoS One; 2016; 11(12):e0168408. PubMed ID: 28036326
[TBL] [Abstract][Full Text] [Related]
35. Diagnosis and prognosis of serum Fut8 for epilepsy and refractory epilepsy in children.
Huang Y; Zhang Z; Chen L
PLoS One; 2023; 18(4):e0284239. PubMed ID: 37053181
[TBL] [Abstract][Full Text] [Related]
36. Astrocyte Elevated Gene-1 as a Novel Clinicopathological and Prognostic Biomarker for Gastrointestinal Cancers: A Meta-Analysis with 2999 Patients.
Luo Y; Zhang X; Tan Z; Wu P; Xiang X; Dang Y; Chen G
PLoS One; 2015; 10(12):e0145659. PubMed ID: 26710214
[TBL] [Abstract][Full Text] [Related]
37. Prognostic and clinicopathological significance of long noncoding RNA H19 overexpression in human solid tumors: evidence from a meta-analysis.
Liu FT; Pan H; Xia GF; Qiu C; Zhu ZM
Oncotarget; 2016 Dec; 7(50):83177-83186. PubMed ID: 27825121
[TBL] [Abstract][Full Text] [Related]
38. A systematic review and meta-analysis of higher expression of folate receptor alpha (FOLR1) predicts poor cancer prognosis.
Liu Y; Lian T; Yao Y
Biomarkers; 2020 Jul; 25(5):367-374. PubMed ID: 32421366
[TBL] [Abstract][Full Text] [Related]
39. A Systems Biology Approach Identifies FUT8 as a Driver of Melanoma Metastasis.
Agrawal P; Fontanals-Cirera B; Sokolova E; Jacob S; Vaiana CA; Argibay D; Davalos V; McDermott M; Nayak S; Darvishian F; Castillo M; Ueberheide B; Osman I; Fenyö D; Mahal LK; Hernando E
Cancer Cell; 2017 Jun; 31(6):804-819.e7. PubMed ID: 28609658
[TBL] [Abstract][Full Text] [Related]
40. Prognostic value of cancer stem cell marker CD133 expression in pancreatic ductal adenocarcinoma (PDAC): a systematic review and meta-analysis.
Li X; Zhao H; Gu J; Zheng L
Int J Clin Exp Pathol; 2015; 8(10):12084-92. PubMed ID: 26722393
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
